Showing results (481-490 of 4,041) with videos related to
Sort By:
Pageof 405
Pharmacoepidemiology and Drug Safety|March 27, 2013
Effect of evidence-based drug therapy on long-term outcomes in patients discharged after myocardial infarction: a nested case–control study in ItalyUrsula Kirchmayer, Mirko Di Martino, Nera Agabiti, et al.Pharmacoepidemiology and Drug Safety|August 13, 2013
Estimating the excess of inappropriate prescriptions of anti-dopaminergic anti-emetics during acute gastroenteritis epidemics in FranceVictoire Roussel, Thomas Tritz, Cécile Souty, et al.Pharmacoepidemiology and Drug Safety|August 14, 2013
Evidence of subgroup-specific treatment effect in the absence of an overall effect: is there really a contradiction?Michal Abrahamowicz, Marie-Eve Beauchamp, Pierre Fournier, et al.Pharmacoepidemiology and Drug Safety|September 17, 2013
Selection bias in pharmacy-based patient surveysP Frisk, S Kälvemark-Sporrong, B WettermarkPharmacoepidemiology and Drug Safety|July 10, 2013
Validation of an algorithm to identify antiretroviral-naïve status at time of entry into a large, observational cohort of HIV-infected patientsNeel R Gandhi, Janet P Tate, Maria C Rodriguez-Barradas, et al.Pharmacoepidemiology and Drug Safety|June 7, 2013
Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectivesJames Leong, Neil McAuslane, Stuart Walker, et al.Pharmacoepidemiology and Drug Safety|June 25, 2013
Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional studyMarie-Laure Laroche, Marie-Christine Perault-Pochat, Isabelle Ingrand, et al.Pharmacoepidemiology and Drug Safety|June 5, 2013
Evaluation of pregnancy outcome records in the German Pharmacoepidemiological Research Database (GePaRD)R T Mikolajczyk, A A Kraut, E GarbePharmacoepidemiology and Drug Safety|July 2, 2013
Atomoxetine for attention deficit hyperactivity disorder in the adulthood: a meta-analysis and meta-regressionRuth Cunill, Xavier Castells, Aurelio Tobias, et al.Pharmacoepidemiology and Drug Safety|April 27, 2013
Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitorsPaul L Hebert, Alexander Marshall McBean, Heidi O'Connor, et al.Pageof 405